Preferred Name | Levobunolol | |
Synonyms |
|
|
Definitions |
A naphthalenone and non-cardioselective adrenergic beta-receptor antagonist with anti-glaucoma activity. Upon administration in the eye, levobunolol blocks beta-adrenergic receptors, thereby causing vasoconstriction. Levobunolol also decreases ciliary's body production of aqueous humor, leading to a decrease in aqueous humor. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C62043 |
|
CAS_Registry |
47141-42-4 |
|
CHEBI_ID |
CHEBI:6438 |
|
Chemical_Formula |
C17H25NO3 |
|
code |
C62043 |
|
Contributing_Source |
FDA |
|
definition |
A naphthalenone and non-cardioselective adrenergic beta-receptor antagonist with anti-glaucoma activity. Upon administration in the eye, levobunolol blocks beta-adrenergic receptors, thereby causing vasoconstriction. Levobunolol also decreases ciliary's body production of aqueous humor, leading to a decrease in aqueous humor. |
|
FDA_UNII_Code |
G6317AOI7K |
|
Has_Salt_Form | ||
in_subset | ||
label |
Levobunolol |
|
Legacy Concept Name |
Levobunolol_Base |
|
Preferred_Name |
Levobunolol |
|
prefixIRI |
NCIT:C62043 |
|
prefLabel |
Levobunolol |
|
Semantic_Type |
Organic Chemical Pharmacologic Substance |
|
UMLS_CUI |
C0006388 |
|
subClassOf |